Tactile Medical to Release Second Quarter of Fiscal Year 2021 Financial Results on August 2, 2021

Rhea-AI Summary

Tactile Systems Technology, Inc. (Nasdaq: TCMD), a medical technology company specializing in at-home treatment devices for chronic diseases, will announce its second quarter fiscal year 2021 financial results on August 2nd, after market close. A conference call hosted by management will take place at 5:00 p.m. ET the same day, with a Q&A session. Participants can join via phone or through a live webcast on the company's investor relations website. Tactile Medical focuses on home therapy devices for conditions like lymphedema and chronic venous insufficiency to improve patient care and reduce healthcare costs.

Positive

• Focus on at-home treatment devices addresses growing market demand for chronic disease management.
• A strong mission to enhance patient quality of life and reduce healthcare costs.
• Established reputation in the market with a network of product specialists and clinical support.

Negative

• None.

MINNEAPOLIS, June 29, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the at-home treatment of chronic diseases, today announced that second quarter of fiscal year 2021 financial results will be released after the market closes on Monday, August 2nd.

Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on August 2nd to discuss the results of the quarter. Those who would like to participate may dial 877-407-3088 (201-389-0927 for international callers) and provide access code 13721055. A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.tactilemedical.com.

For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13721055. The webcast will be archived at investors.tactilemedical.com.

About Tactile Medical

Tactile Medical is a leader in developing and marketing at-home therapy devices that treat chronic swelling conditions such as lymphedema and chronic venous insufficiency. Tactile Medical’s Mission is to help people suffering from chronic diseases live better and care for themselves at home. The Company’s unique offering includes advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates and clinicians. This combination of products and services ensures that tens of thousands of patients annually receive the at-home treatment necessary to better manage their chronic conditions. Tactile Medical takes pride in the fact that our solutions help increase clinical efficacy, reduce overall healthcare costs and improve the quality of life for patients with chronic conditions.

FAQ

When will Tactile Medical release its Q2 2021 financial results?

Tactile Medical will release its Q2 2021 financial results on August 2, 2021, after market close.

What time is Tactile Medical's conference call regarding Q2 2021 results?

The conference call for Tactile Medical's Q2 2021 results will be held at 5:00 p.m. Eastern Time on August 2, 2021.

How can I participate in Tactile Medical's conference call?

You can participate in Tactile Medical's conference call by dialing 877-407-3088 (or 201-389-0927 for international callers) and providing access code 13721055.

Will there be a replay of Tactile Medical's conference call?

Yes, a replay of Tactile Medical's conference call will be available for two weeks at 877-660-6853 (or 201-612-7415 for international callers) with access code 13721055.